CUHK_CCT00042
2005-09-08
Retrospective
RGC grant and Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong
Nil
Nil
CHAN Wai Man
27623168
telephone
CHAN Wai Man
27623168
telephone
A Randomized, Controlled Trial of Photodynamic Therapy with Verteporfin for Choroidal Neovascularization in Pathologic Myopia in Chinese
Yes
2002-04-01
Eye Diseases
Procedure
Photodynamic therapy
24 months
observation
Inclusion criteria: aged 18 years or older CNV either in the subfoveal or juxtafoveal area Area of CNV d 50% of the area of the total lesion Greatest linear dimension of the entire lesion must not exceed 5400 £gm Best-corrected visual acuity score of at least 34 letters (Snellen equivalent, approximately 20/200 or better) Understand the study and sign the informed consent Exclusion criteria: Other clinical features suggesting that the CNV may be secondary to the other causes other than pathologic myopia (such as large drusen, geographical atrophy, choroioretinal scar) Tear (rip) of the retinal pigment epithelium Any other significant concurrent ocular diseases in study eye disease that has compromised or could compromise vision in the study eye History of the other prior forms of treatment including photodynamic therapy, laser, surgery Active hepatitis or clinically significant liver disease Porphyria or hypersensitivity/allergy to treatment (fluorescein, verteporfin) Pregnancy
Randomized
Placebo
Single-blind
Single group
2003-01-01
72
Recruiting
Visual acuity
changes in cnv by angiography and optical coherent tomography
2013-01-14
Yes
None
|
|
|
|
|
---|---|---|---|---|
No documents yet. |